BIOMAT Database Logo BIOMAT Database Logo

Prevalence of Lithuanian mutation among St. Petersburg Jews with familial hypercholesterolemia. 1998

M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Institute for Experimental Medicine, St. Petersburg, Russia.

We used polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis to detect LDL receptor gene defects in the St. Petersburg population. We have found a deltaG197 mutation in several patients of Jewish origin. The mutation named is shown to be responsible for one-third (7/23) of familial hypercholesterolemia (FH) cases in St. Petersburg Jews and absent in patients of Russian descent. The prevalence of a deltaG197 mutation in St. Petersburg Jews is consistent with its origin in Lithuania or Poland. The deltaG197 mutation can be easily detected in polyacrylamide minigels because of formation of specific heteroduplexes during PCR with DNA of heterozygous patients. Taken together with high prevalence of the mutation in St. Petersburg Jews, this observation provides an opportunity for DNA diagnostics of FH in this ethnic group.

UI MeSH Term Description Entries
D007585 Jews An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM. Jew
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008097 Lithuania Country in eastern Europe, bordering the Baltic Sea, between Latvia and Russia, west of Belarus. The capital is Vilnius.
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic

Related Publications

M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.
August 1991, American journal of human genetics,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum.
December 2013, BMC medical genetics,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Prevalence of familial hypercholesterolemia in Johannesburg Jews.
December 1989, American journal of medical genetics,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
[Molecular heterogeneity of familial hypercholesterolemia in the St. Petersburg population].
April 1995, Genetika,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
[Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect].
September 2007, Genetika,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.
May 2001, American journal of human genetics,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
[Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg].
March 2005, Genetika,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Two novel low-density lipoprotein receptor gene mutations (E397X and 347delGCC) in St. Petersburg familial hypercholesterolemia.
December 1998, Molecular genetics and metabolism,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
"Finnish" mutations in LDL receptor gene: a rare cause of familial hypercholesterolemia in St. Petersburg and Petrozavodsk.
July 2013, Bulletin of experimental biology and medicine,
M Mandelshtam, and K Chakir, and S Shevtsov, and V Golubkov, and N Skobeleva, and B Lipovetsky, and V Konstantinov, and A Denisenko, and V Gaitskhoki, and E Schwartz
Prevalence of familial hypercholesterolemia.
September 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!